Carbon Medical Technologies gets US nod for new incontinence product
This article was originally published in Clinica
Executive Summary
The US FDA has given Carbon Medical Technologies approval to sell a second-generation version of its bulking agent for treating women with stress urinary incontinence due to intrinsic sphincter deficiency.